Investors weighing retirement-savings and insurance exposure often encounter two very different profiles: JXN (Jackson Financial Inc.) and MFC (Manulife Financial Corporation). One is a concentrated U.S. annuity specialist, the other a diversified multinational insurer and asset manager. This stock comparison examines their recent relative performance, business models, growth drivers, and market positioning to help both long-term investors and tactical traders assess which name currently offers the more compelling risk-reward profile in the prevailing market environment.
JXN, or Jackson Financial Inc., provides retirement savings and income products, primarily annuities, to U.S. consumers. Its operations are organized around Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks. Recent weeks have been defined by strong operational momentum: full-year 2025 retail annuity sales reached roughly $20 billion, the highest level since 2019, supported by record sales of registered index-linked annuities (RILAs, products whose returns are tied to an equity index with some downside protection).
Management reported adjusted operating earnings of about $1.6 billion for 2025 and a robust risk-based capital (RBC, a regulatory measure of an insurer's capital strength) ratio of 567%. The company returned $862 million to shareholders and raised its quarterly dividend by 12.5%. Sentiment has also been shaped by a strategic partnership with alternative asset manager TPG. However, GAAP net income was pressured by hedging results and an actuarial assumption update, a reminder that reported earnings can swing with market movements even when underlying profitability is solid.
MFC, or Manulife Financial Corporation, is a Canada-headquartered global insurer and wealth manager with a presence across Asia, Canada, and the United States. Recent performance has been anchored by Asia, where core earnings grew about 24% year over year, and by Global Wealth and Asset Management, which saw assets under management and administration (AUMA) climb 13% to roughly $800 billion. Fourth-quarter core earnings per share (EPS, profit allocated to each outstanding share) rose about 8% year over year.
Manulife raised its dividend by roughly 10% and returned nearly C$5.5 billion to shareholders in 2025, while its Life Insurance Capital Adequacy Test (LICAT, a Canadian solvency measure) ratio stood at 136%. New business value (NBV, the present value of future profits from new sales) increased about 8%, with Asia's NBV margin reaching 41.2%. Offsetting factors include net outflows in the wealth business and unfavorable U.S. life insurance claims experience, which have tempered near-term momentum in certain segments.
Tickeron operates hundreds of AI Trading Bots that monitor and trade thousands of different tickers across the market. Because each bot runs its own trading style, strategy, timeframe, and performance track record, only a select group is featured in the curated Trending AI Robots section. These featured bots are chosen for their suitability to current market conditions, with many displaying win rates, trade counts, and profit statistics that range widely depending on their design. Some bots focus on short-term momentum, while others pursue longer-horizon trend strategies across different sets of tickers. For traders looking to apply a systematic, data-driven lens to names like JXN and MFC, exploring the Trending AI Robots page can help identify which automated strategies are currently aligned with the market environment.
The two companies differ most clearly in business model and geography. JXN is a concentrated bet on U.S. retirement products and is highly sensitive to equity markets, interest rates, and policyholder surrender behavior. MFC offers diversification across Asia, Canada, and the U.S., plus a sizable asset-management arm, which spreads risk but also exposes it to currency translation and multiple regulatory regimes.
In growth drivers, JXN's story is tied to rising RILA and fixed index annuity sales and capital-efficient reinsurance structures. MFC's growth is led by Asia's high-margin insurance franchise and its push into private credit and wealth management. On recent momentum, both have posted solid operating results, though JXN's GAAP earnings have been more volatile due to hedging, while MFC has faced outflows in its wealth segment.
From a risk standpoint, JXN's U.S.-centric equity exposure is a double-edged sword in volatile markets, while MFC's diversified model moderates single-market shocks but introduces Hong Kong regulatory and foreign-exchange variables. Market sentiment for both has been constructive, with analysts citing capital return and earnings quality as supportive factors.
Based on observable factors such as trend consistency, earnings stability, and relative positioning, Tickeron's AI framework would likely view MFC as the more balanced candidate at present, favoring its geographically diversified earnings stream and disciplined capital returns. However, JXN's stronger sales momentum and aggressive buyback program could appeal to systems oriented toward shorter-term trend strength. The ultimate ranking depends on the specific strategy weighting assigned to stability versus momentum, but a diversified, multi-factor approach would probably lean toward MFC for its smoother earnings profile while still acknowledging JXN's higher-beta growth characteristics.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for JXN turned positive on October 22, 2026. Looking at past instances where JXN's MACD turned positive, the stock continued to rise in 37 of 43 cases over the following month. The odds of a continued upward trend are 86%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 56 cases where JXN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on JXN as a result. In 67 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
JXN moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for JXN crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +2.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where JXN advanced for three days, in 290 of 376 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 195 of 269 cases where JXN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JXN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
JXN broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. JXN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.946) is normal, around the industry mean (1.337). JXN's P/E Ratio (143.141) is considerably higher than the industry average of (19.773). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.463). Dividend Yield (0.027) settles around the average of (0.047) among similar stocks. P/S Ratio (1.511) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
MFC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 23 of 32 cases where MFC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 72%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 47 cases where MFC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.
MFC moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MFC crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.
Following a +0.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where MFC advanced for three days, in 225 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 191 of 355 cases where MFC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
The 10-day RSI Indicator for MFC moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In 20 of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at 44%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MFC as a result. In 40 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
The Moving Average Convergence Divergence Histogram (MACD) for MFC turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 20 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MFC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. MFC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.537) is normal, around the industry mean (1.337). P/E Ratio (11.686) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.876) is also within normal values, averaging (0.463). Dividend Yield (0.033) settles around the average of (0.047) among similar stocks. P/S Ratio (1.780) is also within normal values, averaging (1.303).
The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MFC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 42 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 53 Fair valued | |
PROFIT vs RISK RATING 1..100 | 4 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 43 | |
P/E GROWTH RATING 1..100 | 76 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| JXN | MFC | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 44% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 66% |
| Momentum ODDS (%) | 1 day ago 78% | 1 day ago 53% |
| MACD ODDS (%) | 1 day ago 86% | 1 day ago 43% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 47% |
| TrendMonth ODDS (%) | 1 day ago 76% | 1 day ago 57% |
| Advances ODDS (%) | 1 day ago 77% | 1 day ago 64% |
| Declines ODDS (%) | 6 days ago 62% | 6 days ago 50% |
| BollingerBands ODDS (%) | 1 day ago 64% | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 72% | 1 day ago 54% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
JXN’s FA Score shows that 1 FA rating(s) are green while MFC’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
JXN’s TA Score shows that 7 TA indicator(s) are bullish while MFC’s TA Score has 6 bullish TA indicator(s).
JXN (@Life/Health Insurance) experienced а +1.52% price change this week, while MFC (@Life/Health Insurance) price change was -3.28% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.56%. For the same industry, the average monthly price growth was +3.48%, and the average quarterly price growth was -0.70%.
JXN is expected to report earnings on Feb 24, 2027.
MFC is expected to report earnings on Feb 17, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, JXN has been loosely correlated with LNC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if JXN jumps, then LNC could also see price increases.
A.I.dvisor indicates that over the last year, MFC has been loosely correlated with MET. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MFC jumps, then MET could also see price increases.